Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07468903 · ClinicalTrials.gov registry record · NA
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07468903 is a NA study that is actively recruiting participants, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 45 participants.
The verdict
NCT07468903, a NA study, is actively recruiting participants, sponsored by Jonsson Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This clinical trial tests the effect of focal radiation therapy, high dose rate-brachytherapy (HDR-BT), in treating patients with prostate cancer. Prostate cancer is the most diagnosed cancer in men and there are many treatments available, including surgery and radiation therapy. Although surgery and radiation therapy improve survival urinary and sexual function can be significantly affected and can be long lasting. HDR-BT, a type of focal radiation therapy also known as internal radiation therapy, uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving HDR-BT may be effective in providing local control while reducing side effects in patients with prostate cancer.
Interventions
- PROCEDURE Biospecimen Collection
- PROCEDURE Biopsy Procedure
- PROCEDURE Multiparametric Magnetic Resonance Imaging
- RADIATION High-Dose Rate Brachytherapy
- PROCEDURE PSMA PET Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-05-11 |
| Est. Completion | 2032-05-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07468903
The ClinicalTrials.gov registry entry for NCT07468903 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT07468903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07468903 about?
NCT07468903 is a clinical study titled "Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer". This clinical trial tests the effect of focal radiation therapy, high dose rate-brachytherapy (HDR-BT), in treating patients with prostate cancer. Prostate cancer is the most diagnosed cancer in men and there are many treatments available, including surgery and radiation therapy. Although surgery an...
What is the current status of trial NCT07468903?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2026-05-11. Estimated completion is 2032-05-11.
What interventions are being tested in trial NCT07468903?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Biopsy Procedure (PROCEDURE), Multiparametric Magnetic Resonance Imaging (PROCEDURE), High-Dose Rate Brachytherapy (RADIATION), PSMA PET Scan (PROCEDURE).
Who is sponsoring clinical trial NCT07468903?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.